<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04542018</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00166423</org_study_id>
    <nct_id>NCT04542018</nct_id>
  </id_info>
  <brief_title>Effects of Low FODMAP Diet on Colonic Epithelial Physiology in Diarrhea-predominant Irritable Bowel Syndrome</brief_title>
  <official_title>Effects of Low FODMAP Diet on Colonic Epithelial Physiology in Diarrhea-predominant Irritable Bowel Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research is studying whether changing an individual's diet may have an impact as a&#xD;
      treatment or outcome for Irritable Bowel Syndrome (IBS). This research will show if diet&#xD;
      might play a role in triggering changes that may cause IBS. This study is being done to learn&#xD;
      if a low FODMAP (fermentable, oligosaccharides, disaccharides, monosaccharides, and polyols)&#xD;
      diet causes changes in the colon lining which mediates improvement in IBS symptoms.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 3, 2020</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients with diarrhea predominant IBS (IBS-D) will undergo 4 weeks of low FODMAP diet. Urine, blood, stool, and colon biopsies will be collected before and after the diet to assess changes in gut physiology.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lactulose Mannitol excretion</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes in cumulative excretion of lactulose and mannitol in timed urine collection before and after low FODMAP diet</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in epithelial permeability</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes in tight junction gene expression, immunostaining of tight junctions in colonic biopsies before and after low FODMAP diet</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in stool microbiome</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes in relative abundance of bacteria before and after low FODMAP diet</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Study patients with IBS-D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with diarrhea-predominant IBS who will undergo a low FODMAP diet for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>a low FODMAP diet for 4 weeks</intervention_name>
    <description>low FODMAP diet for 4 weeks</description>
    <arm_group_label>Study patients with IBS-D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Normal serum studies including serum tissue-transglutaminase antibodies, thyroid&#xD;
             stimulating hormone levels, C-reactive protein or fecal calprotectin, complete blood&#xD;
             count since the onset of symptoms.&#xD;
&#xD;
          -  Normal stool studies including, ova and parasites since the onset of symptoms&#xD;
&#xD;
          -  IBS-SSS score of â‰¥175 at the end of the 7-day screening period&#xD;
&#xD;
        In case of presence of any alarm features and/or elevated inflammatory markers (C-reactive&#xD;
        protein or fecal calprotectin), patients will be eligible if they have been excluded for&#xD;
        inflammatory bowel disease with colonoscopy in the last one year.&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          -  individuals already on a LFD or other dietary restriction such as gluten free diet&#xD;
             within the past 6 months&#xD;
&#xD;
          -  individuals with any known food allergy or insulin-dependent diabetes&#xD;
&#xD;
          -  known history of celiac disease, inflammatory bowel disease or microscopic colitis&#xD;
&#xD;
          -  prior small bowel or colonic surgery or cholecystectomy&#xD;
&#xD;
          -  pregnant patients&#xD;
&#xD;
          -  Antibiotics in the past 3 months&#xD;
&#xD;
          -  Those who regularly use mast cell stabilizers or anti-histaminic or non-steroidal&#xD;
             anti-inflammatory agents (NSAIDs) excluding daily baby aspirin or steroids or&#xD;
             bile-acid binder.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prashant Singh</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Prashant Singh</last_name>
    <phone>734-647-1191</phone>
    <email>singhpr@med.umich.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prashant Singh</last_name>
      <phone>734-647-1191</phone>
      <email>singhp@med.umich.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 1, 2020</study_first_submitted>
  <study_first_submitted_qc>September 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 9, 2020</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Prashant Singh</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

